Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis

doi:10.5009/gnl16563

Editorial

. 2017 Jan 15;11(1):9-10.

doi: 10.5009/gnl16563.

Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis

Soung Won Jeong¹

Affiliations

PMID: 28053298
PMCID: PMC5221855
DOI: 10.5009/gnl16563

Editorial

Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis

Soung Won Jeong. Gut Liver. 2017.

. 2017 Jan 15;11(1):9-10.

doi: 10.5009/gnl16563.

Author

Soung Won Jeong¹

Affiliation

¹ Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

PMID: 28053298
PMCID: PMC5221855
DOI: 10.5009/gnl16563

No abstract available

PubMed Disclaimer

Comment on

Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis.
Kim G, Shim KY, Baik SK. Kim G, et al. Gut Liver. 2017 Jan 15;11(1):93-101. doi: 10.5009/gnl16031. Gut Liver. 2017. PMID: 27538445 Free PMC article. Review.

Cited by

Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease.
Jamil Z, Arif S, Khan A, Durrani AA, Yaqoob N. Jamil Z, et al. J Clin Transl Hepatol. 2018 Jun 28;6(2):135-140. doi: 10.14218/JCTH.2017.00055. Epub 2018 Feb 1. J Clin Transl Hepatol. 2018. PMID: 29951357 Free PMC article.

References

1. Ryu SW, Bok GH, Jang JY, et al. Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver. 2014;8:292–297. doi: 10.5009/gnl.2014.8.3.292. - DOI - PMC - PubMed
1. Park KH, Kwon SH, Lee YS, et al. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:158–164. doi: 10.3350/cmh.2015.21.2.158. - DOI - PMC - PubMed
1. Minami T, Minami Y, Chishina H, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology. 2014;87(Suppl 1):55–62. doi: 10.1159/000368146. - DOI - PubMed
1. Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006;186:158–167. doi: 10.2214/AJR.04.1009. - DOI - PubMed
1. Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol. 2003;180:1583–1591. doi: 10.2214/ajr.180.6.1801583. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Ryu SW, Bok GH, Jang JY, et al. Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver. 2014;8:292–297. doi: 10.5009/gnl.2014.8.3.292. - DOI - PMC - PubMed

[2] Ryu SW, Bok GH, Jang JY, et al. Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver. 2014;8:292–297. doi: 10.5009/gnl.2014.8.3.292. - DOI - PMC - PubMed

[3] Park KH, Kwon SH, Lee YS, et al. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:158–164. doi: 10.3350/cmh.2015.21.2.158. - DOI - PMC - PubMed

[4] Park KH, Kwon SH, Lee YS, et al. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:158–164. doi: 10.3350/cmh.2015.21.2.158. - DOI - PMC - PubMed

[5] Minami T, Minami Y, Chishina H, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology. 2014;87(Suppl 1):55–62. doi: 10.1159/000368146. - DOI - PubMed

[6] Minami T, Minami Y, Chishina H, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology. 2014;87(Suppl 1):55–62. doi: 10.1159/000368146. - DOI - PubMed

[7] Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006;186:158–167. doi: 10.2214/AJR.04.1009. - DOI - PubMed

[8] Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006;186:158–167. doi: 10.2214/AJR.04.1009. - DOI - PubMed

[9] Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol. 2003;180:1583–1591. doi: 10.2214/ajr.180.6.1801583. - DOI - PubMed

[10] Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol. 2003;180:1583–1591. doi: 10.2214/ajr.180.6.1801583. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis

Affiliation

Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical